International Journal of Clinical Pharmacy

Papers
(The median citation count of International Journal of Clinical Pharmacy is 2. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-05-01 to 2025-05-01.)
ArticleCitations
ESCP International Workshop: Pharmacotherapy challenges in the developing years: from conception to adolescence 24–25 April 2024, Bratislava, Slovakia63
Bacillus coagulans TBC169 probiotics for intestinal function recovery after gynecological open surgery: a randomized, double-blind, placebo-controlled trial59
Comment on: “whether temporal discounting is domain‑specific between health outcomes and money—a systematic review and meta‑analysis”50
Implementation status of safety measures to prevent errors with non-oncologic methotrexate: surveys in community and hospital pharmacies37
Effect of CYP2D6 pharmacogenetic phenotype and phenoconversion on serum concentrations of antidepressants and antipsychotics: a retrospective cohort study37
A systematic review of quantitative studies exploring staff views on antipsychotic use in residents with dementia in care homes33
Cost-effectiveness analysis of fruquintinib in Chinese patients with refractory metastatic colorectal cancer31
Non-cardiovascular medication and readmission for heart failure: an observational cohort study27
Characterising pharmacists’ interventions in chronic non-cancer pain care: a scoping review27
Parents’ perspectives towards paediatric confectionary masked medications: a qualitative study27
Global trends in pharmacovigilance-related events: a 30-year analysis from the 2019 global burden of disease study27
Drug-induced liver injury associated with lopinavir-ritonavir in patients with COVID-19: a disproportionality analysis of U.S. food and drug administration adverse event reporting system (FAERS) data26
Efficacy and safety of metformin compared to insulin in gestational diabetes: a systematic review and meta-analysis of Chinese randomized controlled trials26
Response to comment on 'Perioperative esketamine combined with butorphanol versus butorphanol alone for pain management following video-assisted lobectomy: a randomized controlled trial'24
Clinical pharmacist consultant in primary care settings in Slovenia focused on elderly patients on polypharmacy: successful national program from development to reimbursement23
A 5-year trend in the use of sodium-glucose co-transporter 2 inhibitors and other oral antidiabetic drugs in a Middle Eastern country23
Development and evaluation of an assessment of the age-appropriateness/inappropriateness of formulations used in children23
Variation in vancomycin dosing and therapeutic drug monitoring practices in neonatal intensive care units23
Descriptive analysis of reported adverse events associated with anti-obesity medications using FDA Adverse Event Reporting System (FAERS) databases 2013–202022
Attitudes of non-participating general practitioners and community pharmacists towards interprofessional medication management in primary care: an interview study22
Identification of novel signal of proton pump inhibitor-associated drug reaction with eosinophilia and systemic symptoms: a disproportionality analysis21
Medication regimen complexity index and rehabilitation outcomes in post-acute hip fracture patients study: a retrospective study21
Impact of intra-patient variability of tacrolimus on allograft function and CD4 + /CD8 + ratio in kidney transplant recipients: a retrospective single-center study21
Ethical conflicts in patient care situations of community pharmacists: a cross-sectional online survey20
Fluoropyridmidine use and hypertriglyceridemia among Japanese patients: analysis of adverse event database20
Anti‑CGRP monoclonal antibodies in resistant migraine: preliminary real-world effectiveness and clinical predictors of response at two years20
Clinical impact of an individualised clinical pharmacy programme into the memory care pathway of older people: an observational study20
Comparing patient reported and medical record data of adverse drug reactions to anti-seizure drugs19
Real-world data of atezolizumab in patients with previously treated locally advanced or metastatic urothelial bladder cancer19
Environmental scan of current strategies to decrease sedative-hypnotic drug use and promote sleep in hospital patients19
Correlation between the prognostic nutritional index and outcomes in older patients aged ≥ 60 years with chronic heart failure18
Reliability and validity testing of the medicines related - consultation assessment tool for assessing pharmacists’ consultations18
The effectiveness and safety of bevacizumab versus cetuximab in the treatment of colorectal cancer: a systematic review and meta-analysis18
Correction to: 49th ESCP virtual symposium on clinical pharmacy 19.10.2021–21.10.2021 Clinical pharmacy, working collaboratively in mental health care18
Medication errors in emergency departments: a systematic review and meta-analysis of prevalence and severity18
Developing a machine learning model for predicting venlafaxine active moiety concentration: a retrospective study using real-world evidence17
Exploring pharmacist involvement in the discharge medicines reconciliation process and information transfer to primary care: an observational study16
Novel opportunities for clinical pharmacy research: development of a machine learning model to identify medication related causes of delirium in different patient groups16
Barriers to person-centered service design in pharmacy practice: examples, lessons, and potential solutions15
Association of opioid fills with centers for disease control and prevention opioid guidelines and payer coverage policies: physician, insurance and geographic factors15
Consumer views on the use of digital tools for reporting adverse drug reactions: a cross-sectional study14
An umbrella review of the diagnostic value of next-generation sequencing in infectious diseases14
A case–control study on the clinical characteristics of granisetron-related arrhythmias and the development of a predictive nomogram14
Discrepancies in patients' medication lists from pharmacies in Sweden: an interview study before the implementation of the Swedish National Medication List14
Critical care pharmacy service provision and workforce in adult extracorporeal membrane oxygenation centres: a multicentre cross-sectional survey14
Liver injury associated with endothelin receptor antagonists: a pharmacovigilance study based on FDA adverse event reporting system data14
Assessing safety concerns of interstitial lung disease associated with antibody-drug conjugates: a real-world pharmacovigilance evaluation of the FDA adverse event reporting system13
Translation and validation of the CLEO tool in Vietnamese to assess the significance of pharmacist interventions13
Adherence to endocrine therapy in patients with hormone receptor-positive early-stage breast cancer: a retrospective study13
Comparison of various basal insulin dose adjustments for inpatients while unable to eat13
Prolonged oxycodone use and potential risk factors in postoperative patients: a case control study13
Appropriateness of intravenous fluid prescriptions in hospitalised patients: a point prevalence study13
Clinical pharmacists in Dutch general practice: an integrated care model to provide optimal pharmaceutical care12
Pharmacist-led deprescribing of cardiovascular and diabetes medication within a clinical medication review: the LeMON study (Less Medicines in Older Patients in the Netherlands), a cluster randomized 12
How to write a successful grant application: guidance provided by the European Society of Clinical Pharmacy12
How to manage the dose of drugs in cancer patients with acute kidney injury, practical recommendations12
Medication supply at hospital discharge via community pharmacy: a quality improvement study12
Evaluation of osimertinib for advanced non-small cell lung cancer with leptomeningeal metastases: a cost-effectiveness and budget impact analysis12
Complementary and alternative medicine use in self-management of diabetes: A qualitative study of patient and user conversations in online forums11
Comment on “Association of polypharmacy with clinical outcomes and healthcare utilization in older adults with cardiometabolic diseases: a retrospective cohort study”11
Valproic acid for agitation in the intensive care unit: an observational study of psychiatric consults11
Cost-effectiveness of toripalimab plus chemotherapy for advanced esophageal squamous cell carcinoma11
Risk factors for opioid toxicity requiring naloxone rescue in adults: a case-control study11
What do emergency department pharmacist practitioners know and understand about patient safeguarding? A qualitative study11
Embedding cultural competency and cultural humility in undergraduate pharmacist initial education and training: a qualitative exploration of pharmacy student perspectives11
Potentially inappropriate prescribing in a falls clinic using the STOPP and START criteria11
Cardiometabolic risk in people under 40 years with severe mental illness: reading between the guidelines11
Economic evaluation of camrelizumab plus rivoceranib versus sorafenib as first-line therapy for unresectable hepatocellular carcinoma in the United States and China11
Anticholinergic burden and health-related quality of life among adult patients in a resource-limited setting: a cross-sectional study11
Correction to: 50th ESCP Symposium on Clinical Pharmacy, Polypharmacy and ageing - highly individualized, interprofessional, person-centered care11
Impact of a clinical pharmacist on medication safety in mental health Hospital-in-the-Home: a retrospective analysis11
Predicting delirium in older non-intensive care unit inpatients: development and validation of the DELIrium risK Tool (DELIKT)10
Application of a screening tool to understand the medication habits of patients with swallowing difficulty: a prospective observational study10
Cost-effectiveness of miglustat versus symptomatic therapy of Niemann–Pick disease type C10
Prevalence and trends in polypharmacy and excessive polypharmacy: a retrospective national database analysis (2012–2021)10
Opinions and experiences on the provision of care to people with mental illnesses: a qualitative study with Doctor of Pharmacy graduates after a rotation in psychiatry10
Pharmacist-driven antimicrobial stewardship interventions in patients with COVID-19: a scoping review10
Drivers of engagement in virtual communities of practice: a qualitative study of Australian pharmacists’ perceptions and experiences9
Preliminary feasibility assessment of a targeted, pharmacist-led intervention for older adults with polypharmacy: a mixed-methods study9
Development of innovative simulation teaching for advanced general practice clinical pharmacists9
Artificial intelligence in academic writing and clinical pharmacy education: consequences and opportunities9
A consolidated framework for implementation research (CFIR) guided exploration of key informant perspectives on establishing a pharmacist-led anticoagulation service in primary care: a qualitative stu9
Exploring the suitability of a ward-based clinical pharmacy activity collection tool for ambulatory care practice: a mixed-methods study9
Addressing the second victim phenomenon among community pharmacists and its impact on clinical pharmacy practice: a consensus study9
Pharmacists’ involvement in COVID-19 vaccination across Europe: a situational analysis of current practice and policy9
Comment on “The efficacy of zuranolone versus placebo in postpartum depression and major depressive disorder: a systematic review and meta-analysis”9
Identification of factors for a successful implementation of medication reviews in community pharmacies: Using Positive Deviance in pharmaceutical care9
Real-world safety of maribavir: a retrospective study based on signal detection in the FDA adverse event reporting system8
A retrospective cohort study of the effect of rapid versus delayed-result procalcitonin testing on antibiotic use at a community hospital8
How patient-centredness takes place in pharmacy encounters: a critical common-sense interpretation of video-recorded meetings8
Factors associated with Turkish pharmacists’ intention to receive COVID-19 vaccine: an observational study8
SGLT2 inhibitors associated pancreatitis: signal identification through disproportionality analysis of spontaneous reports and review of case reports8
Building an effective medicines optimisation model: a health system approach8
Impact of artificial intelligence on the academic performance and test anxiety of pharmacy students in objective structured clinical examination: a randomized controlled trial8
Exploring the time required by pharmacists to prepare discharge medicine lists: a time-and-motion study8
Barriers and facilitators for the implementation of the CombiConsultation by general practitioners, pharmacists and practice nurses: a qualitative interview study8
Potential drug-drug interactions of immunosuppressants in kidney transplant recipients: comparison of drug interaction resources8
Prescribing at 95 years of age: cross-sectional findings from the Newcastle 85+ study8
Communication issues between pharmacists and d/Deaf people: a qualitative study in Thailand8
Barriers and facilitators to reducing anticholinergic burden: a qualitative systematic review8
Cost-effectiveness of clobazam as an adjunctive treatment for refractory epilepsy in China8
A cost–benefit analysis of hospital-wide medication reviews: a period prevalence study8
Classification of patient characteristics associated with reported adverse drug events to neuraminidase inhibitors: an applicability study of latent class analysis in pharmacovigilance8
Clinical Pharmacist and Clinical Nurse Specialist led medicine optimisation and medication adherence via eArly identifiCation advanCed gEriatric aSsesSment (ACCESS) tool in Senior Adult Oncology Progr8
A quality improvement study on the effect of electronic transmission of a basic discharge medication report on medication discrepancies in patients discharged from the hospital8
Assessing the cost-effectiveness of replacing antimetabolites with mTOR inhibitors in heart transplant immunosuppression in China: a network meta-analysis-based economic evaluation7
Risk factors for readmission among patients receiving outpatient parenteral antimicrobial therapy: a retrospective cohort study7
Patient and hospital staff perspectives on introducing pharmacist-led medication reviews at an orthopedic ward: a mixed methods pilot study7
Comparison of the incidence of nausea and vomiting between linezolid and vancomycin using claims database: a retrospective cohort study7
Pharmacist-led new medicine service: a real-world cohort study in the Netherlands on drug-related problems, satisfaction, and self-efficacy in cardiovascular patients transitioning to primary care7
Antimicrobial utilization and resistance in Pseudomonas aeruginosa using segmented regression analysis: a comparative study between Serbia and eight European Countries7
Discrepancies among equations to estimate the glomerular filtration rate for drug dosing decision making in aged patients: a cross sectional study7
Risk factors for potentially inappropriate medication use in older adults: a cohort study7
Implementation of pharmacist-led deprescribing in collaborative primary care settings7
Sex differences in immune-related adverse events with immune checkpoint inhibitors: data mining of the FDA adverse event reporting system7
Economic cost-benefit analysis of person-centred medicines reviews by general practice pharmacists7
Polypharmacy and medication regimen complexity in transfusion-dependent thalassaemia patients: a cross- sectional study7
A qualitative exploration of the enablers and barriers to the provision of outpatient clinics by hospital pharmacists7
Correction: The effectiveness and safety of bevacizumab versus cetuximab in the treatment of colorectal cancer: a systematic review and meta‑analysis7
Cost-effectiveness analysis of tislelizumab plus chemotherapy versus standard chemotherapy in first-line treatment for extensive-stage small cell lung cancer: perspectives from the United States and C7
Association between sodium-glucose cotransporter 2 inhibitors and cancer: a systematic review and meta-analysis of randomized active-controlled trials7
A randomised, crossover trial exploring the patient perspective and effectiveness of biosimilar adalimumab transition: IBD reference and biosimilar adalimumab cross over study (iBaSS)7
Development of a robust predictive model for neutropenia after esophageal cancer chemotherapy using GLMMLasso7
Investigating the controversy surrounding statin therapy and Achilles tendinopathy using Mendelian randomization analysis7
Sex differences among users of NSAIDs and opioids during COVID-19 Pandemic7
Medication changes and potentially inappropriate prescribing in older patients with significant polypharmacy7
European Society of Clinical Pharmacy: ‘Implementing and scaling sustainable clinical pharmacy’7
Between what is and what could be: a survey of pharmacists’ practices, attitudes, and beliefs in the provision of mental health care7
Psychiatric adverse events associated with semaglutide, liraglutide and tirzepatide: a pharmacovigilance analysis of individual case safety reports submitted to the EudraVigilance database6
Determining sensitivity and specificity of risk scores for QTc interval prolongation in hemato-oncology patients prescribed systemic antifungal therapy: a retrospective cross-sectional study6
Terms used to describe and define activities undertaken as a result of the medication review process: Do they require standardisation? A systematic review6
Publisher Correction to: Bacillus coagulans TBC169 probiotics for the recovery of intestinal function after gynecological laparoscopic surgery: a randomized, placebo-controlled trial6
Accuracy of best possible medication histories by pharmacy students: an observational study6
Delabeling of allergy to beta-lactam antibiotics in hospitalized patients: a prospective study evaluating cost savings6
Correction: Credentialed pharmacist-led home medicines reviews targeting treatable traits and their impact on health outcomes in people with chronic obstructive pulmonary disease: a pre- and post-inte6
Short-term outcome of personalized theory-based pharmaceutical care service on the medication administration problems of family caregivers: a pre-post intervention study6
Remdesivir for COVID-19 and acute kidney injury: disproportionality analysis of data from the U.S. Food and Drug Administration Adverse Event Reporting System6
Development, implementation and evaluation of the digital transformation of renal services in Wales: the journey from local to national6
Abstracts of the 26th Annual Meeting of ESPACOMP, the International Society for Medication Adherence, Berlin, Germany, 17–19 November 20226
Optimising adherence to secondary prevention medications following acute coronary syndrome utilising telehealth cardiology pharmacist clinics: a matched cohort study6
Correction: Development and validation of a Medication Adherence Universal Questionnaire: the MAUQ6
Provision of drug and alcohol services amidst COVID-19 pandemic: a qualitative evaluation on the experiences of service providers6
Population- and individual-level trajectories of opioid prescription patterns among adults with cerebral palsy: a retrospective cohort study6
Drug-related emergency department visits: external validation of an assessment tool in a general emergency department population6
Feasibility of individualised patient modelling for continuous vancomycin infusions in outpatient antimicrobial therapy, a retrospective study6
ESCP Spring Workshop 2023: Advancing clinical pharmacy and care in diabetes and cardiovascular comorbidities—Antwerp, 20–21 April 20236
Scope, content and quality of clinical pharmacy practice guidelines: a systematic review6
Polypharmacy and medication regimen complexity in older patients with hemophilia or von willebrand disease: the M’HEMORRH-AGE study6
Levels of serum lipids predict responses to PD-L1 inhibitors as first-line treatment in small cell lung cancer: an observational study6
Exploring patients’ pharmacy stories: an analysis of online feedback5
Thank you from the Editor-in-Chief5
Developing a theory-based behavior change intervention to improve the prescription of surgical prophylaxis5
Commentary: how person-centred is pharmaceutical care?5
Opioid, sedative, preadmission medication and iatrogenic withdrawal risk in UK adult critically ill patients: a point prevalence study5
Associated factors and safety of the rapidly achieving first therapeutic target of warfarin in hospitalized patients: a retrospective cohort study5
Effectiveness of a structured pharmacist-delivered intervention for patients post-acute coronary syndromes on all-cause hospitalizations and cardiac-related hospital readmissions: a prospective quasi-5
“A little bit more looking…listening and feeling” A qualitative interview study exploring advanced clinical practice in primary care and community pharmacy5
Flight safety risk assessment of self-medication among fighter pilots: a cross-sectional study5
A qualitative exploration of the impact of a hospital electronic prescribing and medicines administration (HEPMA) protocol on junior doctor confidence and competence to prescribe end-of-life care medi5
Group based trajectory modeling to assess adherence to oral anticoagulants among atrial fibrillation patients with comorbidities: a retrospective study5
Developing a machine learning-based predictive model for the analgesic effectiveness of transdermal fentanyl in cancer patients: an interpretable approach5
Effect of duloxetine on pain and opioid consumption after total knee and hip arthroplasty: a systematic review and meta-analysis of randomized controlled trials5
A qualitative exploration of the healthcare challenges and pharmaceutical care needs of people with Parkinson’s and their caregivers5
Evaluating the impact of PD-1 inhibitor treatment on key health outcomes for cancer patients in China5
Glucagon-like peptide 1 receptor agonists and the potential risk of pancreatic carcinoma: a pharmacovigilance study using the FDA Adverse Event Reporting System and literature visualization analysis5
An assessment of the reporting of tapering methods in antidepressant discontinuation trials using the TIDieR checklist5
Application of behavioural theories, models, and frameworks in pharmacy practice research based on published evidence: a scoping review5
Consensus on the criteria for patient prioritization in hospital clinical pharmacy services: a Delphi study5
Influence of a ward-based pharmacist on the medication quality of geriatric inpatients: a before–after study5
Author Correction: Assessing safety concerns of interstitial lung disease associated with antibody-drug conjugates: a real-world pharmacovigilance evaluation of the FDA adverse event reporting system5
Association of silodosin, tamsulosin, and naftopidil with delirium: analysis of the pharmacovigilance database in Japan5
Timeliness of administration of amoxicillin-clavulanic acid and meropenem in a large tertiary care centre5
Improving medication adherence in the community: a purposive umbrella review of effective patient-directed interventions that are readily implementable in the United Kingdom National Health Service5
European Society of Clinical Pharmacy definition of the term clinical pharmacy and its relationship to pharmaceutical care: a position paper5
Co-designing psychosis simulated patient scenarios with mental health stakeholders for pharmacy curricula5
Community pharmacists’ acceptability of pharmacist-delivered depression screening for older adults: a qualitative study5
Comparison of clinical effectiveness of conbercept and ranibizumab for treating retinopathy of prematurity: a meta-analysis5
A cohort study of guselkumab in the treatment of psoriasis refractory to previous biologic therapies: effectiveness, safety and adherence5
Accuracy in patient-reported adverse drug reactions and their recognition: a mixed-methods study5
Exploring the impact of baseline platelet count on linezolid-induced thrombocytopenia: a retrospective single-center observation study5
Medicines-related interventions to support safe transitions for care home residents post hospital discharge: Do hospital-delivered interventions have a role?5
Barriers and enablers to switching from a solid to a liquid formulation of Parkinson’s medication: a theory-based mixed methods investigation4
Additional value of a triggerlist as selection criterion in identifying patients at high risk of medication-related hospital admission: a retrospective cohort study4
Effectiveness of combined proton pump inhibitors and posaconazole prophylaxis against invasive fungal infections in patients with hematologic malignancies: a retrospective study4
Impact of medicine shortages on hospital practice: role of a multidisciplinary medicine shortages team4
Diagnostic evaluation of hypersensitivity reactions to arylpropionic acid derivatives: a descriptive observational study focusing on clinical characteristics and potential risk factors in children4
A model for identifying potentially inappropriate medication used in older people with dementia: a machine learning study4
Development and retrospective evaluation of a clinical decision support system for the efficient detection of drug-related problems by clinical pharmacists4
Point-of-care HIV and hepatitis screening in community pharmacies: a quantitative and qualitative study4
Data mining and analysis for emicizumab adverse event signals based on the Food and Drug Administration Adverse Event Reporting System database4
Community pharmacists' perceptions of their challenges in relation to older adults prescribed psychotropic medications: a focus-group study4
Model-informed precision dosing of vancomycin in clinical practice: an intervention development study4
Causality assessment of adverse drug reactions in neonates: a comparative study between Naranjo's algorithm and Du's tool4
Antimicrobial stewardship for surgical antibiotic prophylaxis and surgical site infections: a systematic review4
Analysis of inpatient and high-risk medicine pharmacist interventions associated with insulin prescribing for hospital inpatients with diabetes4
Correction to: The role of SGLT-2 inhibitors on health-related quality of life, exercise capacity, and volume depletion in patients with chronic heart failure: a meta-analysis of randomized controlled4
Evaluation of medication-related problems in liver transplant recipients with and without an outpatient medication consultation by a clinical pharmacist: a cohort study4
Association of polypharmacy with clinical outcomes and healthcare utilization in older adults with cardiometabolic diseases: a retrospective cohort study4
European Society of Clinical Pharmacy: ‘the prescribing pharmacist: a prescription for better patient care’4
Venous thromboembolism recurrence among one-and-done direct oral anticoagulant users: a retrospective longitudinal study4
Defining quality indicators, pharmaceutical care bundles and outcomes of clinical pharmacy service delivery using a Delphi consensus approach4
Risk factors for linezolid-induced thrombocytopenia in adult inpatients4
Characteristics of hospital pharmacist interventions and their clinical, economic and organizational impacts: a five-year observational study on the French National Observatory4
Risk of major bleeding and thromboembolism in Asian patients with nonvalvular atrial fibrillation using direct oral anticoagulants versus warfarin4
Intentions of hospital pharmacists to use digital technology in their daily practice: a cross-sectional survey using the Theory of Planned Behaviour4
The clinical and economic evidence of the management of urinary tract infections by community pharmacists in women aged 16 to 65 years: a systematic review4
The impact of high on-treatment platelet reactivity and fibrinogen levels on ischemic events in patients with ST elevation myocardial infarction: a prospective observational study4
Prevalence and determinants of intravenous admixture preparation errors: A prospective observational study in a university hospital4
Bacillus coagulans TBC169 probiotics for the recovery of intestinal function after gynecological laparoscopic surgery: a randomized, placebo-controlled trial4
An economic evaluation of vial sharing of expensive drugs in automated compounding4
Rectal use of levetiracetam: best practice report for a stepwise approach for sustainable off-label decision making and treatment4
Superinfection associated with prolonged antibiotic use in non-ventilator associated hospital-acquired pneumonia4
Effect and associated factors of a clinical pharmacy model in the incidence of medication errors in the hospital Pablo Tobón Uribe eacpharmodel study: stepped wedge randomized controlled Trial (NCT0334
Sentiment analysis in medication adherence: using ruled-based and artificial intelligence-driven algorithms to understand patient medication experiences4
Correction to: Cost-effectiveness of check of medication appropriateness: methodological approach4
A qualitative study of the views of healthcare professionals on providing vaccines information to patients4
Just a ‘romantic idea’? A theory-based interview study on medication review implementation with pharmacy owners4
Formal and informal venous thromboembolism risk assessment and impact on prescribing of thromboprophylaxis: a retrospective cohort study4
General practice-based undergraduate pharmacy longitudinal clerkship: a theoretically underpinned qualitative evaluation4
Evaluating biosimilars: safety, efficacy, and regulatory considerations in clinical studies4
Credentialed pharmacist-led home medicines reviews targeting treatable traits and their impact on health outcomes in people with chronic obstructive pulmonary disease: a pre- and post-intervention stu4
Interventions to improve medicines optimisation in frail older patients in secondary and acute care settings: a systematic review of randomised controlled trials and non-randomised studies4
Relative effectiveness and gastrointestinal safety of NSAIDs being prescribed for upper respiratory tract infections: an explorative cohort study in primary care4
Development and validation of a Medication Adherence Universal Questionnaire: the MAUQ4
Cost-effectiveness of tislelizumab versus sorafenib as first-line treatment for unresectable hepatocellular carcinoma: a comparative analysis in China, the United States and Europe4
Culturally and linguistically diverse patients’ perspectives and experiences on medicines management in Australia: a systematic review3
Digital pharmacists: the new wave in pharmacy practice and education3
Warfarin dosing strategies evolution and its progress in the era of precision medicine, a narrative review3
Psychiatric disorders of the combination of levetiracetam either with lacosamide or perampanel: a retrospective cohort study3
Effects of SGLT2 inhibitors on health-related quality of life and functional capacity in patients with heart failure with and without diabetes: a meta-analysis of randomized controlled trials3
Comment on “An umbrella review of the diagnostic value of next-generation sequencing in infectious diseases”: appealing results, but caution is still necessary3
Retrospective evaluation of the impact of non-oncologic chronic drug therapy on the survival in patients with bladder cancer3
Effectiveness and safety of remimazolam tosilate versus propofol for sedation in patients undergoing gastrointestinal endoscopy: a randomized controlled trial3
Cost-effectiveness analysis of PD-1 inhibitors as second-line therapy for advanced or metastatic esophageal squamous cell carcinoma in China: an economic evaluation based on network meta-analysis3
General practice pharmacists’ implementation of advanced clinical assessment skills: a qualitative study of behavioural determinants3
Identification, classification, and documentation of drug related problems in community pharmacy practice in Europe: a scoping review3
Randomized controlled trial for anesthesia during gastroscopy: interactions between remimazolam and propofol in combination with sufentanil3
A cross-sectional study comparing emotional intelligence and perceived stress amongst community pharmacists delivering and not delivering a new service3
Investigating digital determinants shaping pharmacists’ preparedness for interoperability and health informatics practice evolution: a systematic review3
Exploring the safety profile of tremelimumab: an analysis of the FDA adverse event reporting system3
The outcomes of reperfusion therapy with streptokinase versus tenecteplase in ST-elevation myocardial infarction (STEMI): a propensity-matched retrospective analysis in an Asian population3
Implementation of medication reviews in community pharmacy: reaching consensus on stakeholders’ recommendations for mechanisms of change using the nominal group technique3
Medication reconciliation and seamless care led by clinical pharmacists in Slovenia: a national reimbursed program ensuring safe and effective transition of care3
A multi-site evaluation of clinical pharmacist time, motion, interventions and interruptions3
The prevalence of hepatic and thyroid toxicity associated with imatinib treatment of chronic myeloid leukaemia: a systematic review3
Association of drug burden index with delirium in community-dwelling older adults with dementia: a longitudinal observational study3
Cost-effectiveness analysis of selpercatinib versus chemotherapy and pembrolizumab in the first-line treatment of rearranged during transfection fusion–positive non-small cell lung cancer in the Unite3
Clinical pharmacy services are reimbursed in Germany: challenges of real world implementation remain3
The efficacy and safety of fluoxetine versus placebo for stroke recovery: a meta-analysis of randomized controlled trials3
Designing an evidence based community pharmacy service specification for a pharmacogenomic testing service3
0.10951685905457